HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhong Pei Selected Research

xyloketal B

1/2016Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington's disease.
2/2013Xyloketal B exhibits its antioxidant activity through induction of HO-1 in vascular endothelial cells and zebrafish.
12/2009Marine compound Xyloketal B protects PC12 cells against OGD-induced cell damage.
10/2009A novel marine compound xyloketal B protects against oxidized LDL-induced cell injury in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhong Pei Research Topics

Disease

24Infarction (Infarctions)
01/2020 - 02/2002
23Parkinson Disease (Parkinson's Disease)
11/2022 - 10/2003
23Stroke (Strokes)
11/2022 - 02/2002
17Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2022 - 02/2002
10Ischemic Stroke
10/2020 - 04/2008
9Alzheimer Disease (Alzheimer's Disease)
05/2022 - 08/2013
8Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 05/2006
8Cerebral Infarction
07/2015 - 02/2002
7Cognitive Dysfunction
05/2022 - 08/2015
7Huntington Disease (Huntington's Disease)
12/2021 - 09/2006
7Parkinsonian Disorders (Parkinsonism)
01/2021 - 10/2003
7Brain Ischemia (Cerebral Ischemia)
10/2020 - 02/2002
7Inflammation (Inflammations)
01/2020 - 09/2002
7Ischemia
05/2014 - 03/2003
4Mitochondrial Diseases (Mitochondrial Disease)
07/2022 - 12/2005
4Hypoxia (Hypoxemia)
04/2012 - 09/2009
3Neuroinflammatory Diseases
01/2022 - 01/2018
3Hepatolenticular Degeneration (Wilson's Disease)
01/2022 - 06/2011
3Colitis
07/2021 - 01/2018
3Dementia (Dementias)
07/2021 - 01/2017
3Disease Progression
07/2021 - 04/2005
3Gliosis
01/2020 - 01/2012
3Traumatic Brain Injuries (Traumatic Brain Injury)
09/2018 - 04/2002
2Neuroblastoma
07/2022 - 01/2018
2Sleep Wake Disorders
12/2018 - 05/2016
2Hypertension (High Blood Pressure)
06/2018 - 01/2013
2Brain Edema (Cerebral Edema)
06/2015 - 09/2012
2Amyloid Plaque
02/2012 - 02/2011
2Reperfusion Injury
09/2004 - 04/2003
1Paralysis (Palsy)
11/2022
1Microcephaly
01/2022
1Intellectual Disability (Idiocy)
01/2022
1Nervous System Diseases (Neurological Disorders)
01/2022
1Cerebral Small Vessel Diseases
01/2022

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
11/2022 - 12/2005
8Amyloid (Amyloid Fibrils)IBA
01/2022 - 02/2011
7salicylhydroxamic acid (SHAM)IBA
01/2022 - 09/2004
6MelatoninIBA
05/2016 - 02/2002
5Leucine (L-Leucine)FDA Link
11/2020 - 12/2005
41- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
07/2022 - 10/2003
4Phosphotransferases (Kinase)IBA
11/2020 - 12/2005
4SynucleinsIBA
01/2018 - 08/2015
4EnzymesIBA
11/2016 - 01/2010
4xyloketal BIBA
01/2016 - 10/2009
4Glucose (Dextrose)FDA LinkGeneric
04/2012 - 04/2003
4Oxygen (Dioxygen)IBA
04/2012 - 04/2003
3Glial Fibrillary Acidic ProteinIBA
11/2022 - 01/2020
3Bromodeoxyuridine (BrdU)IBA
11/2022 - 04/2008
3Peptides (Polypeptides)IBA
11/2022 - 02/2012
3Amyloid beta-PeptidesIBA
05/2022 - 10/2020
3InflammasomesIBA
07/2021 - 10/2019
3Messenger RNA (mRNA)IBA
01/2020 - 04/2012
3NF-kappa B (NF-kB)IBA
01/2018 - 01/2013
3NestinIBA
02/2017 - 04/2008
3AntioxidantsIBA
02/2013 - 02/2002
3alpha-SynucleinIBA
07/2010 - 04/2005
2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
11/2022 - 04/2013
2Laminin (Merosin)IBA
11/2022 - 05/2006
2Small Interfering RNA (siRNA)IBA
07/2022 - 04/2012
2Biomarkers (Surrogate Marker)IBA
01/2022 - 04/2017
2LipopolysaccharidesIBA
01/2020 - 10/2019
2sodium sulfate (sodium bisulfate)FDA LinkGeneric
01/2019 - 01/2018
2Dextrans (Dextran)FDA Link
01/2019 - 01/2018
2Amyloid Precursor Protein Secretases (beta-Secretase)IBA
06/2018 - 02/2011
2RotenoneIBA
01/2018 - 01/2012
2IronIBA
01/2018 - 01/2016
2SodiumIBA
07/2016 - 04/2002
2CopperIBA
07/2016 - 06/2011
2Pharmaceutical PreparationsIBA
01/2016 - 05/2014
2Huntingtin ProteinIBA
01/2016 - 09/2006
2ebselenIBA
07/2015 - 11/2007
2Neuroprotective AgentsIBA
09/2012 - 04/2003
23-n-butylphthalide (butylphthalide)IBA
04/2012 - 09/2009
2W 12IBA
05/2011 - 09/2009
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
10/2003 - 09/2002
2Free Radical ScavengersIBA
04/2003 - 02/2002
1Reserpine (Serpasil)FDA Link
11/2022
1Dopamine (Intropin)FDA LinkGeneric
11/2022
1Nogo Receptor 1IBA
11/2022
1ClaudinsIBA
11/2022
1Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA
11/2022
1bafilomycin A1IBA
11/2022
1AntigensIBA
11/2022
1rho-Associated KinasesIBA
11/2022
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
11/2022
1rhoA GTP-Binding ProteinIBA
11/2022
1Myelin Basic ProteinIBA
11/2022
1Sphingosine-1-Phosphate ReceptorsIBA
11/2022
1MethyltransferasesIBA
01/2022
14- (benzylamino)- 2- ((2- (3- chloro- 4- hydroxyphenyl)ethyl)amino)pyrimidine- 5- carboxamideIBA
01/2022
16-methyladenineIBA
01/2022
1Aquaporin 4IBA
01/2022
118S Ribosomal RNAIBA
01/2022
1OligonucleotidesIBA
12/2021
1Antisense OligonucleotidesIBA
12/2021

Therapy/Procedure

6Therapeutics
12/2021 - 04/2008
4Intraperitoneal Injections
02/2014 - 04/2002
3Deep Brain Stimulation
02/2018 - 02/2011
2Transplantation
04/2020 - 06/2011
2Injections
05/2014 - 03/2003